Comments

XOMA Royalty Stock Price, Quotes and Forecasts

Q: What sector and industry does XOMA Royalty (XOMA) operate in?

XOMA Royalty is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

XOMANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$27.49

0.170.62%

At close: -

$27.49

0.000.00%

After Hours: Jun 27, 4:17 PM EDT

Turnstone Biologics (TSBX) announced it will be merged with XOMA Royalty (XOMA) on Friday, June 27, 2025

XOMA Royalty (XOMA) Forecast

News Earnings XOMA Royalty (XOMA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

XOMA Royalty Stock Price, Quotes and Forecasts | NASDAQ:XOMA | Benzinga

Explore XOMA Royalty stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for XOMA.

Open	$27.70
Close	$27.49
Volume / Avg.	269.60K / 40.27K
Day Range	$26.51 - $27.80
52 Wk Range	18.35 - 35.00
Market Cap	$328.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	65
Short Interest	1.89%
Days to Cover	6.11

Recent News

FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base

FDA's Genetic Metabolic Diseases Advisory Committee will review Zevra Therapeutics' arimoclomol for Niemann-Pick disease type C on August 2. PDUFA decision expected by September 21.

Vandana Singh

Lexicon Pharmaceuticals Reports Q1 Loss, Misses Revenue Estimates

Lexicon Pharmaceuticals (NASDAQ: LXRX) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to loss of $0.17 per share a year ago. These figures are adjusted for non-recurring items.

Zacks

Biotech Royalty Aggregator XOMA To Acquire Small Cancer-Drug Developer Kinnate Biopharma

XOMA acquires Kinnate Biopharma for $2.3352 per share, with potential additional cash. The acquisition is expected to close in April 2024.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$27.70
Close	$27.49
Volume / Avg.	269.60K / 40.27K
Day Range	$26.51 - $27.80
52 Wk Range	18.35 - 35.00
Market Cap	$328.97M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	65
Short Interest	1.89%
Days to Cover	6.11

About XOMA Royalty Corp.

Sector

Health Care

Industry

Biotechnology

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy XOMA Royalty (XOMA) stock?

You can purchase shares of XOMA Royalty (NASDAQ:XOMA) through any online brokerage.

View our list of the best stock brokerages

Who are XOMA Royalty (XOMA) competitors?

Other companies in XOMA Royalty’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Humacyte (NASDAQ:HUMA), Altimmune (NASDAQ:ALT), Prothena Corp (NASDAQ:PRTA) and Olema Pharmaceuticals (NASDAQ:OLMA).

What is the forecast, or price target, for XOMA Royalty (XOMA) stock?

XOMA Royalty has a consensus price target of $59.67.

What is the current price for XOMA Royalty (XOMA)?

The stock price for XOMA Royalty (NASDAQ: XOMA) is $27.49 last updated June 27, 2025 at 4:17 PM EDT.

Does XOMA Royalty (XOMA) pay a dividend?

There are no upcoming dividends for XOMA Royalty.

When is XOMA Royalty (NASDAQ:XOMA) reporting earnings?

XOMA Royalty’s Q2 earnings are confirmed for Tuesday, August 12, 2025.

Is XOMA Royalty (XOMA) going to split?

There is no upcoming split for XOMA Royalty.

What sector and industry does XOMA Royalty (XOMA) operate in?

XOMA Royalty is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.